ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Canagliflozin in Study Participants With Various Degrees of Impaired Hepatic (Liver) Function

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01186588
Recruitment Status : Completed
First Posted : August 23, 2010
Last Update Posted : May 29, 2013
Sponsor:
Information provided by (Responsible Party):
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2011
  Actual Study Completion Date : April 2011